A Phase II Study of Lenalidomide in Patients With Relapsed or Refractory HTLV-1 Associated Adult T Cell Leukemia/Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2016
At a glance
- Drugs Lenalidomide (Primary)
- Indications Leukaemia; T cell lymphoma
- Focus Therapeutic Use
- 22 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Jan 2011 New trial record